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ABSTRACT 
 
Islam Nazmul, Master of Science: June: 2018, Public Health 
Title: Investigating the utilization of healthcare services to manage respiratory tract 
infections (RTIs) among Qatari patients attended selected primary healthcare centers in 
Qatar. 
Supervisor of Thesis: Mohammad Fasihul Alam. 
 
Background: Respiratory-Tract-Infections (RTIs) are a common cause for most of 
the GP consultations and antibiotic use at primary care. The study aims to investigate the 
pattern, distribution, and determinants of several healthcare services use (RTI-related GP 
visits, antibiotic use, other medication uses and tests and investigations) to manage RTIs 
among local Qatari patients presented at the selected Primary Health Care Centers 
(PHCCs) in Qatar. 
 
Methods:   A retrospective cross-sectional study was conducted in the selected 
seven (7) Primary Health Care Centers in Qatar for which a complete primary healthcare 
services data is available on the CERNER system from July 2015 to December 2017. We 
analyzed electronic data on RTIs-related GP consultations, antibiotic use, other medication 
uses, and tests and investigations recorded by the PHCC. Trends were investigated by 
employing linear regression analysis, including months and seasonal dummies as 
independent-variables. The rates of services use (per 1000 total cause visits) were presented 
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by age-categories, gender, and comorbidity-status. We also analyzed individual patient-
level count data on RTI-related 4 selected healthcare services use.  A separate negative 
binomial regression model was used to identify determinants of healthcare services use.  
 
Results:  A total of 171,447 RTI visits made by 58,786 patients during July-2015 
to December-2017. The Mean age ±SD of participants is 24.80±18.5 years, among them 
38.79% falls to age group 5-19 and 33.53% belongs to 20-44. Of the total patients, 48.91% 
are male and the rest are female. Highest number of patients with a comorbidity of Diabetes 
(12.85%), followed by Hypertension (10.54%). We have found no difference in the month-
to-month rates of RTI-related GP visits (per 1000 total visits) over the study period (non-
significant decreasing trend). However, there was a significant decreasing trend in the 
monthly rates of antibiotics consumption and an increasing trend in the tests/investigations 
done but there was no clear increasing or decreasing trend in the monthly rates of other 
medications use. As expected, we found lower number of RTI related healthcare services 
use during the summer months. After the bi-variate analysis of individual patient-level data 
of selected 4 health care services across age-categories, gender and various comorbidity 
status, we found healthcare services varied significantly across age-categories (younger 
patients relatively used more healthcare services compared to older patients) and whether 
patients had one of the five comorbidities. We have also found that age and comorbidity 
status (whether patients had a comorbidity or not) were important predictors for 
determining individual patient-level healthcare services use.   
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Conclusion: In this study, antibiotic consumption for RTIs significantly decreased, 
as did consultation rates but investigations use rate significantly increased. The large 
seasonal variation indicates additional likelihoods to decrease healthcare service use. After 
the bi-variate analysis of individual patient-level data of selected 4 healthcare services 
across age-categories, gender and various comorbidity status, healthcare services varied 
significantly across age-categories and whether patients had one of the five comorbidities. 
We have also found that age and comorbidity status (whether patients had a comorbidity 
or not) were important predictors for determining individual patient-level healthcare 
services use.  So, the first ever study investigating the utilization of healthcare services use 
by RTI patients presented at the 7 PHCC healthcare centers in Qatar, which may help 
policymakers to comprehend the scale of the utilization and to plan a better management 
of RTIs at primary care setting in Qatar. 
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عدوى الجهاز التنفسي تعد سببا شائعا لمعظم استشارات أطباء العموم ولاستخدام المضادات الحيوية  خلفية:
لاستخدام لخدمات الرعاية الصحية في الرعاية الصحية الأولية. تستهدف هذه الدراسة استقصاء نمط وتوزيع ومحددات ا
المتنوعة (زيارات أطباء العموم ذات الصلة بعدوى الجهاز التنفسي، استخدام المضادات الحيوية، استخدامات الأدوية 
في مراكز الرعاية  الأخرى، والاختبارات والفحوص) لمعالجة عدوى الجهاز التنفسي لدى المرضى القطريين المحليين
 المختارة بقطر. )sCCHP(الصحية الأولية
قطر لديها بيانات في  في سبعة مراكز للرعاية الصحية الأولية مرجعية تم إجراء دراسة مقطعية  طرق البحث:
 5102( سيرنر) من يوليو  السجلات الطبية الإلكترونية نظاممكتملة عن خدمات الرعاية الصحية الأولية متوفرة على 
البيانات الإلكترونية عن استشارات الأطباء المتعلقة بعدوى الجهاز التنفسي، واستخدام . قمنا بتحليل 7102إلى ديسمبر 
المضادات الحيوية واستخدامات الأدوية الأخرى، والاختبارات والفحوص المسجلة من قبل مراكز الرعاية الصحية 
ت الشكلية للشهور والمواسم كمتغيرات الأولية. تم اختبار الاتجاهات باستخدام تحليل الانحدار الخطي باعتبار المتغيرا
مستقلة. تم عرض معدلات استخدام الخدمات (لكل ألف من إجمالي أسباب الزيارات) من خلال الفئات العمرية، الجنس، 
والحالة المرضية. قمنا أيضا بتحليل بيانات عددية فردية على مستوى المريض عن استخدام أربع خدمات رعاية مختارة 
الجهاز التنفسي. استخدم نموذج انحدار ثنائي سلبي منفصل لتحديد محددات استخدام خدمات الرعاية  متعلقة بعدوى
 الصحية.
مريضا خلال  68785زيارة بسبب الإصابة بعدوى الجهاز التنفسي قام بها  744171إجمالا هناك  النتائج:
سنة، من بينهم  5.81 ± 08.42ركين هو الانحراف المعياري للمشا ±. متوسط العمر 7102إلى ديسمبر  5102يوليو 
% من إجمالي  19.84عاما.  44-02% ينتمون إلى الفئة العمرية   35.33عاما و 91-5%ينتمون للفئة العمرية  97.83
%)،  58.21المرضى ذكور والباقي إناث. أعلى عدد من المرضى كانوا من الذين لديهم السكري كمرض مصاحب (
%). لم نجد فرقا في المعدلات الشهرية لزيارات أطباء العموم المتعلقة بعدوى الجهاز  45.01يليه ارتفاع ضغط الدم (
 التنفسي (لكل ألف زيارة إجمالية) على مدار فترة الدراسة (اتجاه تناقصي غير مهم إحصائيا).
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تزايدي تجاه في المعدلات الشهرية لاستهلاك المضادات الحيوية وا ملحوظكان هناك اتجاه تناقصي غير أنه 
ي المعدلات الشهرية فواضح تزايدي أو تناقصي لم يكن هناك اتجاه ، لكن التي أجريتالفحوص  في الاختبارات /
أثناء أشهر  ذات الصلة بعدوى الجهاز التنفسي مواردللأقل استخداما كما هو متوقع، وجدنا ولاستخدام الأدوية الأخرى. 
 الصيف.
خدمات رعاية صحية مختارة عبر  أربعللبيانات الفردية على مستوى المريض عن المتغير بعد التحليل ثنائي 
في الفئات ملحوظ وجدنا أن خدمات الرعاية الصحية تختلف بشكل  الأمراض المصاحبة،الفئات العمرية والجنس وحالة 
تختلف فيما إذا كان والمرضى كبار السن) بمقارنة أكثر نسبيا  صحية سنا خدمات الأصغرالمرضى  استخدمالعمرية (
كان  إذا(الأمراض المصاحبة وحالة  عمر. وجدنا أيضا أن الةمن الأمراض المصاحبة الخمسالمرضى يشكون من واحد 
الفردية على مستوى  حيةلتحديد استخدام خدمات الرعاية الصكانت منبئات مهمة لا) مرض مصاحب أم المرضى لديهم 
 المريض.
انخفض استهلاك المضادات الحيوية لعدوى الجهاز التنفسي بشكل ملحوظ : في هذه الدراسة، الاستنتاج
إحصائيا، وبالمثل معدلات الاستشارات لكن معدل استخدام الفحوص ازداد بشكل ملحوظ. ويدل التغير الموسمي الكبير 
للبيانات الفردية تغير على وجود احتمالات إضافية لتقليل استخدام موارد الرعاية الصحية. بعد إجراء التحليل ثنائي الم
الأمراض المصاحبة خدمات رعاية صحية مختارة عبر الفئات العمرية والجنس وحالة  أربععلى مستوى المريض عن 
المختلفة، تفاوتت خدمات الرعاية الصحية بصورة ملحوظة في الفئات العمرية وفيما إذا كان المرضى لديهم واحدا من 
كذلك أن العمر وحالة المرض المصاحب (فيما إذا كان المرضى لديهم أمراض الأمراض المصاحبة الخمسة. وجدنا 
مصاحبة أم لا) كانا منبئين مهمين لتحديد استخدام خدمات الرعاية الصحية الفردية على مستوى المريض.هذه الدراسة 
ضى عدوى الجهاز هي الدراسة الأولى على الإطلاق التي تستقصي عبء استخدام موارد الرعاية الصحية من قبل مر
التنفسي في سبعة مراكز للرعاية الصحية الأولية تابعة لمؤسسة الرعاية الصحية الأولية في قطر، ما قد يساعد واضعي 
 السياسات على فهم حجم العبء والتخطيط لمعالجة أفضل لعدوى الجهاز التنفسي في بيئة الرعاية الأولية بدولة قطر.
  
   
viii 
 
 
ACKNOWLEDGMENTS 
 
 I would like to thank the Primary Health Care Corporation (PHCC) in Qatar for 
providing me the necessary data for the study. Especially, I would like to thank both 
Research Section Team and the Health Information Management Team of the PHCC (Mr. 
Mujeeb C Kandy, Mr. Muhammad Kawsar Harun) for helping me out with data issues. It 
would have been impossible to carry out this thesis without their help. Furthermore, I 
would like to express my gratitude to my supervisor Dr. Mohammed Fasihul Alam for 
introducing me to the topic, as well as for his useful comments, remarks, and guidance 
throughout my research works. I would like to thank my loved ones, who have supported 
me throughout entire process. I will be ever grateful to them. 
 
  
   
ix 
 
 
TABLE OF CONTENTS 
ACKNOWLEDGMENTS ........................................................................................... viii 
CHAPTER 1: INTRODUCTION ....................................................................................1 
Significance and Implications ........................................................................................ 14 
Aim ............................................................................................................................... 15 
Objectives ..................................................................................................................... 15 
CHAPTER 3: METHODS ............................................................................................. 16 
Study Design: A retrospective cross-sectional study. .................................................. 16 
Study Setting: ............................................................................................................ 16 
Study Population: ....................................................................................................... 17 
Source of the Data: ..................................................................................................... 17 
Missing data:.............................................................................................................. 18 
Primary Healthcare services includes: ........................................................................ 18 
Variables: ................................................................................................................... 18 
Sampling Method- ..................................................................................................... 19 
Instrument/Tool for data collection- ........................................................................... 20 
Inclusion criteria- ....................................................................................................... 20 
Exclusion criteria: ...................................................................................................... 20 
   
x 
 
Statistical Analysis: .................................................................................................... 20 
Storage Plan-.............................................................................................................. 23 
Ethical Considerations- .............................................................................................. 23 
CHAPTER 4: RESULTS ............................................................................................... 24 
Trend analysis of rates (per 1000 total all-cause visits) of healthcare services use: ..... 26 
Analysis of individual patient-level healthcare services use: ....................................... 41 
Determinants by Negative Binomial regression analysis:............................................ 49 
CHAPTER 5: DISCUSSIONS AND CONCLUSIONS.................................................. 60 
Strengths of the study: ................................................................................................ 63 
Weaknesses of the study: ........................................................................................... 64 
Further Research: ....................................................................................................... 65 
Concluding Remarks: ................................................................................................. 66 
 
   
1 
 
CHAPTER 1: INTRODUCTION 
 
World-wide population structure has gone through the transition to massive 
changes i.e. increased life expectancy, reduced mortality due to infectious diseases, 
increased mortality due to chronic non-communicable diseases, accidents and violence (1). 
Similarly, to the rest of the world, Qatar,  also has a significant reduction in the proportion 
of deaths due to infectious diseases but the number of some common infectious diseases 
like Respiratory Tract Infections (RTIs), Otitis media, Intestinal Infection and Skin & Soft 
tissue infection still remained high in the last decades, with a substantial impact on 
morbidity and mortality (2). 
Antibiotic medications abuse has prompt an expanding rate of antimicrobial medication 
resistance. As there are currently less new antimicrobial drugs being created, it is vital to 
safeguard the viability  and accessibility of antimicrobial drugs for future generations 
(3).The Chief Medical Officer's yearly report of UK for 2011 (3)  advanced the idea of 
antimicrobial stewardship, which implies that pointless or improper utilization of 
antimicrobial agents ought to  maintain a strategic distance  in order to limit the choice of 
antimicrobial safe strains on living beings. In context of expanding antimicrobial 
medication protection, the abuse of anti-infection drugs can prompt superfluous symptoms 
and increment in the number of future consultations for RTIs (4) (5).  
According to the Global Burden of the Disease (GBD) study in 2015, Infectious Diseases  
causes 5.7 million deaths worldwide (6). Among them RTIs (mainly lower) alone causes 
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3.2 million deaths and has the fourth highest incidence in the world, with more than 290 
million cases, accounting for 4.9% of all deaths in the world (7). Even in primary care, 
RTIs are a common cause for consultation and antibiotics are commonly prescribed for it 
(8). Globally, RTIs account for around 60% of antibiotic prescribing in primary care (8) 
(9). 
The State of Qatar took its first steps in establishing a primary healthcare system and started 
to provide healthcare services through a range of clinics as early as 1954. In 1978 the 
Ministry of Health developed a comprehensive scheme for building a primary healthcare 
system which was submitted to the Council of Ministers and the scheme included the 
launching of primary healthcare services through 9 health centres, covering different parts 
of the country, and capable of providing basic and essential health and medical services 
(preventive and curative). Since then, all effort has been spent to enhance healthcare 
standards. Overtime, services were planned with the objective of being the first health 
defence line, and it continued to improve both in terms of quantity and quality.  
Currently, the Primary Health Care Corporation is operating through 23 primary healthcare 
centres distributed into three regions, namely Central, Western, and Northern. Thirteen of 
these centres are located in Doha city, while the rest of centres are located in populated 
areas in all parts of the country in order to provide a wide variety of different types of 
healthcare services that depend on the location and needs of each area throughout a set of 
objectives which focuses on keeping the health of population, and prevention from 
diseases, in addition to patient diagnose and treatment, and the provision of a long-term 
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and constant support to patients and their families from infants to elderly, children, adults, 
married couples, and mothers. Many health centres provide specialty services to the 
community aiming to enhance self-care model as well as healthy life style manner (10). 
In Qatar, various recent studies and statistics show that annual mortality by the Infectious 
diseases for all age is around 3.5% which is 84 per 100,000 people and Annual years of 
Healthy Life lost is 7,252 per 100,000 people (11) (12) (13). These common infections are 
Upper Respiratory Tract Infection, Lower Respiratory Tract Infection, Otitis media, 
Intestinal Infection and Skin and Soft Tissue Infections (14). These infectious diseases are 
not only common in Qatar but can also be seen in other middle east countries (15). 
Despite enormous burden with infectious diseases, there is limited data on the extent of 
healthcare services which are used for treating and managing respiratory tract infections 
(RTIs) in primary care setting in the middle-eastern countries. However, a few studies on 
disease burden have done in some other countries, but in Qatar this kind of study has never 
been done before. Therefore, the present study has been undertaken to investigate the 
utilization and distribution of healthcare services used to manage one of the common 
infections, Respiratory Tract Infections (RTIs) among Qatari patients who presented at the 
selected Primary Health Care Centres (PHCCs) in Qatar. This study also explored the trend 
and determinants of health care services used by Qatari patients attending PHCCs for RTI 
during July 2015 to December 2017. The study results may help policy makers to 
understand the scale of the problem, will provide evidence on the pattern of healthcare 
services used for treating RTI patients at primary healthcare setting and ultimately will help 
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to guide a better dealing of the issue at PHCC-level. It may also help the Government to 
prioritize a more efficient health intervention to decrease the economic and disease burden. 
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CHAPTER 2: LITERATURE REVIEW 
 
According to Bosch et al., Respiratory Tract Infection is mainly divided into Upper 
Respiratory Tract Infection and Lower Respiratory Tract Infections (16). Regular features 
of RTIs are nasal obstruction, sore throat, tonsillitis, pharyngitis, laryngitis, sinusitis, otitis 
media, common cold and pneumonia (17). Most of the RTIs are viral in nature i.e. rhino 
virus, Adenovirus, Influenza A virus, Influenza B virus, Human parainfluenza viruses, 
Human respiratory syncytial virus and in other instances the cause is bacterial (18). Most 
basic microbes' are Streptococcus pyogenes (19).Other bacterial causes are Streptococcus 
pneumoniae, Haemophilus influenzae, Corynebacterium diphtheriae, Bordetella pertussis, 
and Bacillus anthracis. RTIs can also be fungal or helminth in origin, but these are far less 
common (19). 
 
Management of Respiratory Tract Infections in Primary Care: 
The UK national guidance on the self-limiting infection control claimed that most 
patients presenting with acute RTIs in primary care can be managed by either no or a 
delayed antibiotic prescribing, with prescriptions only being used if symptoms do not 
improve (9). 
A systematic review by Reveiz et al. indicated that prescribing antibiotics for URTIs  is 
not a suggested exercise especially antibiotics like penicillin V and erythromycin are not 
effective for acute laryngitis (20). The authors found that Erythromycin may improve voice 
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disturbances following one week and cough following two weeks, yet any uncertain 
subjective advantage isn't superior to anything the opposite impacts, cost, and the risk of 
microbes creating protection from the anti-infection agents. The study concluded with a 
proposal that, health specialists ought to firmly urge the doctors to discourage 
antimicrobials to treat normal RTIs because anti-microbial practice does not genuinely 
diminish recovery time for these viral illnesses. 
Some non-Scandinavian countries suggests penicillin V as the primary line option and the 
European Society for Clinical Microbiology and Infectious Disease prescribed amoxicillin 
or an antibiotic medication to bring down RTIs (21). No solid proposal has indicated a 
particular antimicrobial as best  exact anti-infection treatment (22). As most genuine 
intense respiratory infections are identified with pneumococci, penicillin V may without 
movement against gram-positive cocci (minimal inhibitory concentration 0.06 μg/ml) and 
few symptoms (23). 
A Canadian study with the aim of examining the general practitioners’ (GPs’) prescribing 
patterns for acute respiratory tract infections (ARTIs) as compared with national guidelines 
also recommends penicillin V as a first line antibiotic for RTI (24). 
Young population who are generally given syrup or other fluid formulations of 
antimicrobials, the high utilization of amoxicillin is additionally announced in studies from 
Norway(24) and this is most likely due to better taste of amoxicillin compared to the 
primary line option penicillin V. Similarly, it may be sensible to prescribe amoxicillin to 
secure compliance with treatment (25), also a  recent study has suggested that resistance 
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selection by amoxicillin is mostly short-lived (less than 1 month) (26). Yet, the long-term 
use of antibiotics and increased risk of resistance due to prolonged use of antibiotics (27) 
needs attention, and antibiotic prescribing should be targeted only to the patients with a 
high chance of receiving benefit (28), (29). 
 
 
Factors Associated with Managing Respiratory Tract Infections in Primary Care: 
A Danish study based on routine registry data from the out-of-hours (OOH) 
registration system on patient contacts and ATC-coded prescriptions, described the 
frequency and characteristics of antibiotic prescribing for different types of contacts found 
a much higher prescription rate of 26.1% (30). 
A Dutch cohort study on febrile children, recommends that GPs advise more antimicrobial 
drugs in the OOH service than in regular GP exercise (31). 
A Canadian study by Gjelstad et al,. explored probable determinants of antibiotic practice 
patterns (24). After analysis they found that high number of practice was linked to 
inappropriate antibiotic counselling and GPs’ practice rate recognised as a determinant of 
antimicrobial counselling for ARTIs in a Norwegian study. The study also found that GPs 
with a high volume of over-all yearly encounters had higher prescription rates for ARTIs 
and GPs with fewer yearly patient meetings used additional non-penicillin V 
antimicrobials. GPs of maximum quintile with respect to the total yearly encounter 
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percentage had 1.6 times the odds of advising antibiotics compared with GPs in the lowest 
quintile. 
A Swedish study investigated, how prescription patterns for RTIs differed among medical 
student, residents, younger GPs, older GPs and locums (32). The study concluded that elder 
GPs pick broad-spectrum antibiotics to a higher mark than younger GPs and medical 
student.  
According to Gjelsted et al. female clinicians had overall higher prescription rate than their 
male colleagues, but the authors couldn’t find any significant difference in the rate of 
broad-spectrum antibiotics prescription (24).  
But according to B. Lindberg et al. female clinicians consult fewer broad-spectrum 
antibiotics than male clinicians (33). They also found a high broad-spectrum consultation 
rate in the aging population with acute bronchitis and pneumonia but found no relation 
between median duration of consultations per session nor median days between duty hours 
and broad-spectrum antibiotics.  
Similar studies also identified some other factors that have been shown to be related with 
consulting drugs for RTIs in primary care and these factors are age (higher for elder 
patients) and lengthy list of patients (34, 35). An American study based on National 
Ambulatory Medical Care Survey identifies some factor are related to Antibiotic 
Prescribing for ARTIs in Adult Primary Care (36). They found that Physicians specialist 
filed, and terrestrial province is the most strongly associated factor for a high prescribing 
rate. They also found that black race, absence of health coverage, and health keeper group 
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membership is related with lesser rates of consultation, but patient’s age, sex, and 
municipal vs countryside setting were not significantly associated with consulting choice. 
 
Burden of Managing Respiratory Tract Infections in Primary Care: 
In Norway (Lindberg et al., 2017) (33), the antibiotic prescription frequency 
increased significantly  along with increasing activity level, measured as shorter median 
duration of consultations per session, from 28.7% (reference) in the least busy quintile of 
meetings to 36.6% in the busiest quintile of meetings. 
In a recent study by (Aabenhus et al. 2017) (37) based on Danish general practice, ARTIs 
accounted for a high number (456,532) of antimicrobial consultations delivered between 
July 2012 and June 2013. Likewise, the practise of second-line agents increased with 
oldness for all indications and encompassed additional 40% of the prescriptions in patients 
more than 75 years. Females were more frequently given antibiotics irrespective of clinical 
need.In Germany (Hueber et al. 2017) (38), the average practice rate of antibiotics was 
24.9% and prescription  rate in high practitioners was 43.5% compared to 8.5% in low 
practitioners. 
In Columbia (Lara-Oliveros et al. 2016) (39), the children were the significant users of 
health care services. They also found that main use of services was attributed to 
hospitalizations, diagnostic tests and pharmaceutical costs. 
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Most of the UK general practices consult antibiotics to young and middle-aged adults with 
RTIs at rates that are prominently more than what is clinically proved (Gulliford et al., 
2014) (40). 
In the regions of Arctic Canada (Mustafa et al. 2017) (41), the healthcare services use in 
Nunavut and Nunavik are much higher than that in Northwest Territories and remain 
among the highest worldwide. The study also concluded that, the services of these 
admissions are remarkably high due to the mixture of very high rates of admission, very 
expensive medical evacuations and lengthy hospitalizations. 
A recent study by (Li et al. 2016) (42) found that, the burden and use of hospital healthcare 
services of RTIs increases with age in these countries, with hospitalizations driving the 
costs of RTI upwards in the aging populace. 
In Australia (Dallas et al. 2014) (43), The authors found significant (p<0.001) result related 
to antibiotic prescription, for URTI it was 21.6% and 73.1% for acute 
bronchitis/bronchiolitis. They also found significant (p<0.001) result for the use of services 
like Pathology tests (32%) and Imaging tests (31%). 
In Netherlands (Jansen et al., 2006) (44), Yearly more than 10% of the children’s were 
prescribed at least one antibiotic following an RTI and antibiotics were prescribed in more 
than half of events of LRTI. Compared with elder children, under two years of age were 
more frequently treated with antibiotics and the result was significant.  
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Burden of Antimicrobial Resistance (AMR): 
Different studies strongly suggest that a reduction in antibiotic prescriptions can 
prevent drug resistant bacteria. (45) (46).  
Spellberg et al. have identified antimicrobial resistance as a great threat in the modern 
world (47). The authors also suggested that, global collective actions need to be taken to 
address the danger, including a proposal for a world-wide agreement on antimicrobial 
resistance. They also stated that additional element and consideration is still required to 
identify and measure tendencies in resistance on the intercontinental level. 
 According to the systematic review by G Spurling et al. found no variation in the change 
of signs among those treated with antibiotics immediately and those with postponed 
medications. Additionally, different studies demonstrated no difference in patient 
satisfaction, patient complications, side effects between late and no antimicrobials. The 
authors concluded with the suggestion of the reduction in the use of inappropriate 
antimicrobials.  (48). 
Lee et al. suggested few policies that are needed for reducing the AMR i.e. Antibiotic 
stewardship to sustain the worth of current and upcoming antibiotics, the use of timing of 
prescription of effective antibiotics sooner rather than later, to develop at least ten new 
antibiotics by the year 2020 (42). 
Several studies suggested that Antibiotic stewardship programmes is most convenient for 
reducing rates of AMR (49) (50). The studies also highlighted that unnecessary antibiotic 
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usage has become one of the highest contributors to the growth of AMR. Since the start of 
the antimicrobial time, antimicrobial agents have been utilized to treat an extensive variety 
of disease. Misuse of antimicrobials has become the key reason for increasing levels of 
AMR. The principle issue is that specialists will endorse anti-microbials to uneducated 
people who trust that anti-infection agents can cure almost all diseases, including viral 
diseases like the common cold. 
According to Llor et al. antimicrobial resistance is a world-wide public health challenge, 
which has enhanced by the misuse and abuse of antibiotics (51). Authors also said that, 
AMR can lead to severe infections, complications, extended hospital stays and high 
mortality because over use of antibiotics is linked with high risk of contrary effects, 
recurrent re-admission and increased medicalization of self-managing illnesses. Antibiotic 
over prescription is a problem in primary care, where virus is the most common cause of 
infections. Authors concluded the study with the suggestion of importance of need to multi-
layered interventions to reduce misuse of antimicrobials. They also suggested that, 
interferences should involve the implementation of the strategy of omitting the over-the-
counter sale of antimicrobials, the use of antimicrobial stewardship programmes, the active 
contribution of physicians in assessments, the use of effective fast point-of-care tests, the 
promotion of delayed antibiotic prescribing approaches, the development of counselling 
skills with patients with the support of information leaflets and the act upon more realistic 
studies in primary care with the results that are of clinicians’ interest, such as complications 
and clinical outcomes. 
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Significance and Implications 
 
The focus of the research is to investigate the healthcare services use of managing 
RTIs in Qatar, which is one of the leading causes of morbidity and mortality in the world. 
Exploration on the epidemiology and management of RTIs has provided significant 
understandings into predictive factors for these conditions. Yet, there is little data on the 
healthcare services use in managing RTIs. So, this research will provide a wider, broader 
assessment of the healthcare services use associated with the managing Respiratory tract 
infections in Qatar. The study result may help the policymakers to comprehend the size of 
the issue and how to better arrangement the issue at PHCC-level. If patients are better 
managed at primary care, it may reduce some healthcare services at hospital-level, e.g. 
hospitalizations. It may also assist the Government to organize and ensure efficient 
wellbeing for its RTI patients with limited resources. 
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Aim 
To investigate the pattern, distribution, and determinants of a number of healthcare 
services use (RTI-related GP visits, antibiotic use, other medication uses and tests and 
investigations) to manage RTIs among local Qatari patients presented at the selected 
Primary Health Care Centers (PHCCs) in Qatar. 
 
Objectives 
1. To investigate the utilization of the Primary healthcare services to manage 
Respiratory tract infections among Qatari patients presented at the selected PHCCs in 
Qatar. 
2. To examine the trends of selected Primary healthcare services used by Qatari 
patients attending selected Primary Health Care Centers for RTIs during the period July 
2015 to December 2017. 
3. To investigate the determinants of individual patient level healthcare services 
during July 2015 to December 2017. 
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CHAPTER 3: METHODS 
 
Study Design: A retrospective cross-sectional study. 
 
Study Setting: 
This study conducted in the selected seven (7) primary health care centers in Qatar for 
which a complete primary healthcare services data is available on the CERNER system 
from July 2015 to December 2017. Although there are in total 23 PHCCs in Qatar, the 
CERNER electronic database has complete patient-level information for only 7 primary 
healthcare centers over the study period. The availability of primary care electronic 
database in Qatar has also restricted the study duration for only being 2 and half years. 
 
Name of the seven Primary Health Care Centers: 
1- Al Daayen Health Centre. 
2- Gharrafat Al Rayyan Health Centre 
3- Leghwairiya Health Centre 
4- Omar Bin Al Khattab Health Center  
 5- Al Sheehaniya Health Center  
6- Al Wakra Health Center  
7- West Bay Health Center 
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Study Population: 
❖ Qatari patients attended PHCC healthcare centers for respiratory tract infections 
(RTIs) are selected for this study.  
❖ This study included only Qatari Patients attending selected seven PHCC for the 
respiratory tract infections between July 2015 to December 2017 of all ages. 
 
Source of the Data: 
 This study used the secondary data from the CERNER electronic database system 
of the Primary Health Care Corporation, Qatar on the RTIs among Qatari patients. The 
recorded diagnosis in the database were considered final and not verified externally. The 
database does not include hospital-level information for patients, and there is no data 
linkage currently available to track healthcare services used at hospital by the RTI patients 
presented at primary healthcare centers. The study does not include non-Qatari people 
because RTI profile is not complete in the CERNER for non-Qatari population. 
Data was validated by the PHCC validation team by taking random sample from each 
month one encounter from each healthcare center. 
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Missing data: 
 As trained physicians enter data into the CERNER and CERNER itself programed 
in a way that there is less chance of error. For the variables of interests, there was no 
missing data in the CERNER database provided by the PHCC. 
 
 
Primary Healthcare services includes: 
 Number of GP visits, number of antibiotics use, other medications taken by the 
patient except antibiotic, number of tests and investigations prescribed by clinicians, etc. 
Other medication includes number antipyretics, bronchodilator and oxygen therapy 
prescribed.  
 
The following information were collected from electronic records- 
Variables: 
Demographic Variables 
1. Age 
2. Sex / gender 
3. Co-morbidity status 
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Individual patient level variables- monthly  
 
1. International Classification of Diseases, 10th Revision (ICD-10) for the 
Respiratory tract infections. 
2. Number of GP/clinicians visits for the Respiratory tract infections 
3. Were antibiotics prescribed? - (Y/N) 
4. If yes, number of antibiotics (item) prescribed for the Respiratory tract infection. 
5. Number of other medications (item) prescribed for the Respiratory tract infection. 
6. If any lab tests and investigations (e.g. X-ray, blood tests, etc.) - Name/type of 
tests, number of tests, etc. 
 
Outcome:  
Utilization of healthcare services related to RTI i.e. GP visits, antibiotic use, 
medications use, tests and investigations. 
 
Sampling Method-  
 All health centers for which data were complete on the CERNER during 2015 to 
2017. 
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Instrument/Tool for data collection-  
 This study was conducted in the selected seven Primary Health Care Centers of 
Qatar for which a complete data is available on the CERNER system from July 2015 to 
December 2017. This study analyzed the secondary data from the electronic data base 
system of PHCC, Qatar on the RTIs with ICD code-10 of the infection. The recorded 
diagnosis in the database were considered final and not verified externally. 
 
Inclusion criteria-  
1. Qatari Patients attended selected seven PHCC for RTIs between July 2015 to December 
2017 of all ages. 
 2. Diagnosis done by either clinical assessment or by using diagnostic test. 
Exclusion criteria: 
1. Qatari Patients attended selected seven PHCCs not for the RTIs between July 2015 to 
December 2017of all ages. 
 2. Non-Qatari Patients attended selected seven PHCCs for the RTIs between July 2015 to 
December 2017of all ages. 
 
Statistical Analysis: 
Overview of Analysis Plan-  
 Descriptive statistics included frequency with percentages for categorical variables, 
mean and standard deviation for continuous variables. The rate of use of each PHCC 
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healthcare services were calculated in terms of per 1000 total GP visits. These rates were 
presented according to age category, gender, and co-morbid status. 
The mean differences of outcome variables between categories of patient’s characteristics 
were compared according to nature of the variables. Two samples non-parametric Mann-
Whitney test for non-normally distributed outcomes between categories of binary variables 
and non-parametric Kruskal Wallis test for categorical independent variables with more 
than two categories. 
Trends were investigated in monthly rates of 4 selected healthcare services use by RTI 
patients. We converted each of the 4 healthcare services use into monthly rate and reported 
in per 1000 total visits. For example, monthly rate of RTI-related visit is calculated by 
 
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑅𝑇𝐼−𝑟𝑒𝑙𝑎𝑡𝑒𝑑 𝑣𝑖𝑠𝑖𝑡𝑠 𝑓𝑟𝑜𝑚 𝑎𝑙𝑙 7 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑐𝑒𝑛𝑡𝑒𝑟𝑠 𝑖𝑛 𝑎 𝑚𝑜𝑛𝑡ℎ
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑙𝑙−𝑐𝑎𝑢𝑠𝑒 𝑣𝑖𝑠𝑖𝑡𝑠 𝑓𝑟𝑜𝑚 𝑎𝑙𝑙 7 ℎ𝑒𝑎𝑙𝑡ℎ𝑐𝑎𝑟𝑒 𝑐𝑒𝑛𝑒𝑡𝑒𝑟𝑠 𝑖𝑛 𝑡ℎ𝑎𝑡 𝑚𝑜𝑛𝑡ℎ
  x 1000. 
 
Following the above formula, we calculated monthly rate of RTI-related visit, antibiotic 
and other medication use, and tests/investigations use for 30 months during July 2015 and 
December 2017. The trends in the monthly rate of each of the 4 selected healthcare services 
use over 30 months study period were presented in a graph. Since there is a possible 
seasonal influence on the occurrence of RTIs, hence an effect on the RTI-related healthcare 
services use, this was accounted for in the estimated regression model of trend analysis. 
Since most of the dependent variables follow an approximate normal distribution, we 
estimated the following simple linear regression to investigate the trend in monthly rate of 
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various RTI-related healthcare services used by patients: 
Y = a +b1 Months + b2 Q2 + b3 Q3 + b4 Q4 + e ------------------------ (1) 
where ‘Y’ is the dependent variable (monthly utilization rate for one of the 4 healthcare 
services use), ‘Months’ represents time-trend of 30 months of the study period (1-30, where 
1 for July 2015, 2 for August 2015, ……., 30 for December 2017). Quarters ‘Q1’ – ‘Q4’ 
are seasonal dummies, where ‘Q1’ refers to January to March, Q2 refers April to June, Q3 
refers July to September and Q4 refers to October to December of a year, Q1 is a reference 
category and e represent the random error. From the regression model, b1 estimates the 
monthly trend in the dependent variable (‘Y’) after adjusting for seasonal effects, b2, b3 
and b4 are the regression coefficients for respective seasonal dummies. β –coefficients and 
their p-value with 95% Confidence Intervals were reported. All statistical analyses were 
two-sided, and a p-value less than 0.05 considered to be significant. 
Negative binomial regression model was used to identify determinants of healthcare 
services use because of over-dispersed count outcome variables. At first, univariate 
analysis was used to identify important covariates and explore unadjusted association 
(IRR) between variables and the outcomes, the significance was assessed by Wald statistic 
p-value or Likelihood ratio test if the categorical variable had more than two levels. All 
variables whose p-value <0.25 along with the variables of known clinical importance were 
selected and the multivariable model is fitted (the initial full model). Then the significance 
of variable was assessed using its Wald statistic p-value, and variables that did not make 
contribution to the model (with p-value >0.05) were eliminated and a new smaller model 
fitted. These two models were then compared by using likelihood ratio test (LRT) for 
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model comparison to make sure that the new smaller model fits as well as the initial full 
model. 
Analysis were done by using Microsoft Excel and STATA statistical software package 
15.0. 
 
Storage Plan-  
Electronic data were kept in password protected folder in a computer with the 
access only to investigators and team members. Papers and other printed materials were 
locked in a cabinet. 
 
Ethical Considerations- 
1. Formal approval obtained from QU-IRB (Ref No: QU-IRB 875-E/18) 
2. Formal approval obtained from PHCC-IRB of Qatar. (Ref No: PHCC/RS/17/10/013). 
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CHAPTER 4: RESULTS 
 
A total of 171,447 RTI-related visits made by 58,786 patients during July-2015 to 
December-2017. The Mean age ±SD of patients is 24.80±18.5 years, among them 38.79% 
falls to age group 5-19 and 33.53% belongs to 20-44. Of the total patients, 48.91% are male 
and the rest are female. Highest number of patients with a comorbidity of Diabetes 
(12.85%), followed by Hypertension (10.54%). Table-1. 
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Table-1: Descriptive of all RTI patients (N=58,786) attended primary healthcare centres 
in Qatar during July 2015 to December 2017. 
 
Variables  Continuous data (Mean ±SD), 
Categorical data (Number & %) 
Age (Mean ±SD) (24.80±18.5) 
Age-category < 5 years N (%) 6,163 (10.48)  
5 -19 years N (%) 22,803 (38.79)  
20 -44 years N 
(%) 
19,709 (33.53) 
 
45+ years N (%) 10,111 (17.20) 
Gender 
  
 
Male N (%) 28,753 (48.91)  
Female N (%) 30,033 (51.09) 
Diabetes 
  
 
Yes N (%) 7,555 (12.85)  
No N (%) 51,231 (87.15) 
Hypertension 
  
 
Yes N (%) 6,195 (10.54)  
No N (%) 52,591 (89.46) 
Asthma 
  
 
Yes N (%) 4,293 (7.30)  
No N (%) 54,493 (92.70) 
Dyslipidaemia 
  
 
Yes N (%) 3,481 (5.92)  
No N (%) 55,305 (94.08) 
Obesity 
  
 
Yes N (%) 2,743 (4.67)  
No N (%) 56,043 (95.33) 
 
 
 
The most common infections were unspecified acute upper respiratory infection, 
unspecified acute pharyngitis and acute nasopharyngitis (common cold). 
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Trend analysis of rates (per 1000 total all-cause visits) of healthcare services use: 
Total 30 months (July 2015 to December 2017) rates of four selected healthcare 
services were used to observe the monthly trend.  
 
 
Table: 2 Descriptive of monthly rates of four (4) selected health care services during July 
2015 to December 2017. 
 
Variables Mean Std. Dev. 
RTI-related GP visits 186.4 46.52 
Antibiotics 59.9 14.48 
Other medication 507.2 127.91 
Investigations 8.7 5.43 
 
 
 
The Mean rate of RTI-related GP visits (±SD) is 186.4 (±46.52), Mean Antibiotic-use rate 
(±SD) is 59.9 (±14.48), Mean Medication use rate (±SD) is 507.2 (±127.91) and Mean 
Investigations use rate (±SD) is 8.7 (±5.43) (Table-2). 
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Table-3 produces results from the estimated regression model (1) for the trend analyses in 
monthly rates of 4 selected healthcare services use. We observed that monthly rates of RTI-
related GP visits during July 2015 and December 2016 decreased by 0.5 visit (per 1000 
total visits) which was not statistically significant (p=0.441). However, the rate of RTI-
related antibiotic use decreased significantly by about 0.8 (per 1000 total visits) over the 
study period (p ˂0.001). Although for both other medications use and tests and 
investigations there was a slightly increasing trend in the monthly rates, it was statistically 
significant for tests/investigations ((p ˂0.001) whereas for other medications use the trend 
was not significant (p=0.797). As expected, RTI-related GP visits were significantly lower 
in quarters 2 and 3 (Q2, Q3) compare to Q1 of winter months (Jan.-Mar.) 
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Table-3: Estimated regression model (1) showing the trend analysis of monthly rates of 4 
selected healthcare services use by RTI patients during July 2015 to December 2017. 
 
RTI-related GP visits Estimates P-value 95% Confidence Interval R² 
Months -0.47 0.441 -1.70 0.76 0.69 
Q1 Reference 
    
Q2 -47.87 0.007 -81.30 -14.45 
 
Q3 -63.14 ˂0.001 -93.47 -32.81 
 
Q4 26.76 0.083 -3.79 57.31 
 
      
RTI-related Antibiotic 
use 
Estimates P-value 95% Confidence Interval R² 
Months -0.84 ˂0.001 -1.26 -0.43 0.64 
Q1 Reference 
    
Q2 -5.77 0.298 -16.97 5.42 
 
Q3 -15.64 0.004 -25.79 -5.48 
 
Q4 8.66 0.093 -1.57 18.89 
 
      
Other Medications use Estimates P-value 95% Confidence Interval R² 
Months 0.50 0.797 -3.50 4.51 0.57 
Q1 Reference 
    
Q2 -103.62 0.060 -212.15 4.91 
 
Q3 -127.71 0.013 -226.17 -29.24 
 
Q4 95.72 0.058 -3.48 194.91 
 
      
Tests/Investigations Estimates P-value 95% Confidence Interval R² 
Months 0.49 ˂0.001 0.33 0.64 0.65 
Q1 Reference 
    
Q2 -1.69 0.410 -5.83 2.46 
 
Q3 -0.37 0.843 -4.12 3.39 
 
Q4 0.71 0.703 -3.08 4.50 
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Figures 1-4 present the trend in the monthly rate of 4 selected healthcare services use by 
RTI patients from July 2015 to December 2017. It is clear from these figures that, although 
there is no difference in the month-to-month rates of RTI-related GP visits over the study 
period, there is a decreasing trend in the monthly rate of RTI-related antibiotics 
consumption and an increasing trend in the tests/investigations done (Figures 2 and 4). 
Figure 3 does not show a clear trend in the monthly rates of other medications use. 
 
 
Figure 1: Monthly rate of RTI-related GP visits (per 1000 total all-cause visits) during July 
2015 to December 2017. 
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Figure 2: Monthly rate of RTI-related antibiotics use (per 1000 total all-cause visits) during 
July 2015 to December 2017. 
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Figure 3: Monthly rate of RTI-related other medication use (per 1000 total all-cause visits) 
during July 2015 to December 2017. 
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Figure 4: Monthly rate of RTI-related tests/investigations use (per 1000 total all-cause 
visits) during July 2015 to December 2017 
 
 
 
 
Although we have data only for calendar 3 years, we presented yearly rates of 4 selected 
primary health care services use by age-categories, gender and co-morbidity status.   
Table-4 shows the rates of RTI-related GP visits (per 1000 total all-cause visits) during 
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during the study period among all co-morbidities groups. For the Diabetes rate was 
increased from 22.86 to 27.64 per 1000 total-cause visits and for obesity is decreased from 
10.03 to 9.95 per 1000 total-cause visits.  
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Table-4: Rate of RTI-related GP visits (per 1000 total all-cause visits) during 2015 to 2017 
across age categories, gender and Co-morbidities. 
 
RTI Visits/1000 visit 
 
2015 2016 2017 
Age Groups 
    
 
< 5 years 25.55 22.50 20.00 
 
5 -19 years 86.50 83.44 75.50 
 
20 -44 years 62.90 59.86 53.68 
 
45+ years 27.45 31.18 33.83 
Gender 
    
 
Male 100.61 97.10 90.91 
 
Female 101.79 99.88 92.10 
Co-morbidities 
    
Diabetes 
 
22.86 25.67 27.64 
Hypertension 
 
18.31 21.23 24.06 
Asthma 
 
17.85 18.58 18.95 
Dyslipidaemia 
 
10.29 12.15 13.97 
Obesity 
 
10.03 9.90 9.95 
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Table-5 provides rate of RTI-related antibiotics use (per 1000 total all-cause visits) during 
2015 to 2017 by age categories, gender and Co-morbidities. Antibiotic use rate in the three 
years is showing overall decreasing trend among age categories. Overall, the rate of 
antibiotic use was decreasing for all age groups except older populations, 45+ years. For 
those aged 5 to 19 years, the rate of antibiotic use decreased from 31.62 to 21.76 per 1000 
total all-cause visits, which highest among all age groups. For both male and female RTI 
patients, antibiotic use was decreasing during 2015 to 2017. For patients with various 
comorbidities the rate was also either decreasing or stable, except for hypertension for 
which the rate was showing a small increasing trend. The rate of antibiotic use was highest 
for patients with diabetes (22.86 to 27.64 per 1000 total all-cause visits) but remained 
almost stable (7.36 to 7.31 per 1000 total-cause visits) and lowest for patients with obesity 
with decreasing trend (3.49 to 2.75 per 1000 total-cause visits). 
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Table-5: Rate of RTI-related antibiotics use (per 1000 total all-cause visits) during 2015 to 
2017 among age category, gender and Co-morbidities. 
 
Antibiotics 
 
2015 2016 2017 
Age Groups 
    
 
< 5 years 9.73 8.30 6.59 
 
5 -19 years 31.62 28.63 21.76 
 
20 -44 years 21.24 18.67 14.32 
 
45+ years 9.02 9.25 9.10 
Gender 
    
 
Male 35.62 32.35 25.78 
 
Female 36.00 32.51 25.99 
Co-morbidities 
    
Diabetes 
 
7.36 7.69 7.31 
Hypertension 
 
5.98 6.28 6.34 
Asthma 
 
5.93 5.86 4.96 
Dyslipidaemia 
 
3.19 3.58 3.76 
Obesity 
 
3.49 3.09 2.75 
 
Table-6 gives the rates other medication use (per 1000 total all-cause visits) during 2015 
to 2017 among age categories, gender and Co-morbidities. Age group 5 to 19 years had the 
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highest rate of other medication use in the three years among all age groups (234.38 to 
213.98 per 1000 total-cause visits) and age group 45+ years has the lowest rate of 
medication use (69.63 per 1000 total-cause visits) for the year 2015 and age group <5 years 
has the lowest rate of medication use (64.67 to 61.31 per 1000 total-cause visits) for the 
year 2016 and 2017. All the co-morbidities are showing increasing trend, in the diabetes 
rate was increased from 58.16 to 75.06 per 1000 total-cause visits, highest among all co-
morbidities group and in the obesity, rate was increased from 25.87 to 27.07 per 1000 total-
cause visits. 
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Table-6: Rate of other medication use (per 1000 total all-cause visits) during 2015 to 2017 
among age category, gender and Co-morbidities. 
 
Other Medications 
 
2015 2016 2017 
Age Groups 
    
 
< 5 years 76.46 64.67 61.31 
 
5 -19 years 234.38 222.59 213.98 
 
20 -44 years 162.88 152.69 149.38 
 
45+ years 69.63 78.07 90.63 
Gender 
    
 
Male 269.67 256.71 255.89 
 
Female 273.67 261.31 259.41 
Co-morbidities 
    
Diabetes 
 
58.16 64.65 75.06 
Hypertension 
 
46.49 53.10 64.88 
Asthma 
 
46.19 47.84 51.77 
Dyslipidaemia 
 
25.98 30.12 37.77 
Obesity 
 
25.87 25.19 27.07 
 
Table-7 provides rates of RTI related investigations use (per 1000 total all-cause visits) 
during 2015 to 2017 among age category, gender and Co-morbidities. The rate of 
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tests/investigations uses over three years study period from 2015 to 2017 is showing an 
overall increasing trend. For those aged 5 to 19 years, the Investigations rate of use 
increased from 0.84 to 5.61 per 1000 total-cause visits, highest among all age groups and 
those aged 45+ years the rate was increased from 0.22 to 1.52 per 1000 total-cause visits, 
lowest among all age groups. Among the co-morbidities diabetes has the highest rate (0.16 
to 1.43 per 1000 total-cause visits) and obesity has the lowest rate (0.07 to 0.56 per 1000 
total-cause visits) of using investigations. 
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Table-7: Rate of RTI related investigations use (per 1000 total all-cause visits) during 2015 
to 2017 among age category, gender and Co-morbidities. 
 
Investigations 
 
2015 2016 2017 
Age Groups < 5 years 0.45 1.35 1.94 
 
5 -19 years 0.84 3.9 5.61 
 
20 -44 years 0.49 2.37 3.6 
 
45+ years 0.22 0.94 1.52 
     
Gender Male 0.9 4.35 6.2 
 
Female 1.09 4.22 6.47 
Co-morbidities 
    
 
Diabetes 0.16 0.81 1.43 
 
Hypertension 0.14 0.62 1.08 
 
Asthma 0.19 0.66 1 
 
Dyslipidaemia 0.04 0.32 0.62 
 
Obesity 0.07 0.34 0.56 
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Analysis of individual patient-level healthcare services use: 
Table-8 Delivers the distribution and bi-variate analysis of individual patient-level 
number of RTI-related GP visits across age-categories, gender and various comorbidity 
status. The mean ±SD number of the RTI related visits differs significantly (p-value 
<0.001) among the levels of age groups. Age group less than 5 years (3.18±3.56), 5 to 19 
years (3.16±3.10) had the highest and age group 20 to 44 years (2.62±2.69) had the lowest 
mean number of RTI related visits. The Mean ±SD number RTI related visits between male 
and female was statistically not significant but there was statistically significant difference 
between the mean use of RTI related visits for Diabetes (3.08±3.22, p-value <0.001), 
Hypertension (3.17±3.34, p-value <0.001), Asthma (3.87±3.94, p-value <0.001), 
Dyslipidaemia (3.24±3.38, p-value<0.001) and Obesity (3.24±3.27, p-value <0.001). 
 
 
 
 
 
 
 
 
 
   
42 
 
Table-8: Bi-variate analysis of individual patient-level number of RTI related GP visits 
during July 2015 to December 2017 (N=58,786). 
 
Variables 
 
 RTI-related GP visits 
      Mean ±SD 
p-value 
Age Groups <5 years 3.18±3.56  <0.001 
 
5 to 19 years 3.16±3.10 
 
 
20 to 44 years 2.62± 2.69 
 
 
45+ years 2.80±2.83 
 
Gender Male 2.95±3.11 0.159 
 
Female 2.88±2.87 
 
Diabetes Yes 3.08±3.22 <0.001 
 
No 2.89±2.95 
 
Hypertension Yes 3.17±3.34 <0.001 
 
No 2.89±2.94 
 
Asthma Yes 3.87±3.94 <0.001 
 
No 2.84±2.89 
 
Dyslipidaemia Yes 3.24±3.38 <0.001 
 
No 2.89±2.96 
 
Obesity Yes 3.24±3.27 <0.001 
 
No 2.90±2.98 
 
 
Table-9 Provides the distribution and bi-variate analysis of individual patient-level 
number of Antibiotic use across age-categories, gender and various comorbidity 
status. The mean ±SD number of Antibiotic use varies significantly (p-value 
<0.001) between the levels of age groups. Age group less than 5 years (1.13±1.63), 
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5 to 19 years (1.03±1.42) had the highest and age group 20 to 44 years (0.78±1.19) 
had the lowest mean number of Antibiotic use. There was statistically significant 
difference between the mean use of antibiotics for Diabetes (0.88±1.32, p-
value=0.005), Hypertension (0.90±1.37, p-value=0.01), Asthma (1.14±1.63, p-
value <0.001) and Obesity (0.98±1.39, p-value=0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
44 
 
Table-9: Bi-variate analysis of individual patient-level number of Antibiotic use during 
July 2015 to December 2017 (N=58,786). 
 
Variables 
 
Number of Antibiotic use 
    Mean ±SD 
p-value 
Age Groups <5 years 1.13±1.63 <0.001 
 
5 to 19 years 1.03±1.42 
 
 
20 to 44 years 0.78±1.19 
 
 
45+ years 0.81±1.22 
 
Gender Male 0.93±1.38 0.129 
 
Female 0.90±1.31   
 
Diabetes Yes 0.88 ±1.32 0.005 
 
No 0.90±1.31   
 
Hypertension Yes 0.90 ±1.37 0.011 
 
No 0.92±1.34 
 
Asthma Yes 1.14±1.63 <0.001 
 
No 0.90±1.32 
 
Dyslipidaemia Yes 0.92±1.36 0.557 
 
No 0.92±1.34 
 
Obesity Yes 0.98±1.39 0.010 
 
No 0.91±1.34  
 
*p-value <0.05 significant, based on non-parametric Mann-Whitney and Kruskal-Wallis 
test.  
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Table-10 Delivers the distribution and bi-variate analysis of individual patient-level 
number of other medications use across age-categories, gender and various comorbidity 
status. Age group less than 5 years (9.45±11.27) had the highest and 20 to 44 years 
(6.93±7.73) had the lowest mean number of other medication use and the mean use of 
medication was statistically significantly different (p-value<0.001). Also, statistically 
significant difference was present between the mean use of other medication for Diabetes 
(8.04±8.87, p-value <0.019), Hypertension (8.22±9.18, p-value <0.001), Asthma 
(10.25±11.06, p-value <0.001), Dyslipidaemia (8.39±9.20, p-value<0.001) and Obesity 
(8.50±8.92, p-value <0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
46 
 
Table-10: Bi-variate analysis of individual patient-level number of other medications use 
during July 2015 to December 2017 (N=58,786). 
 
Variables 
 
Number of Other Medications use 
     Mean ±SD 
p-value 
Age Groups <5 years 9.45±11.27 <0.001 
 
5 to 19 years 8.65±9.23 
 
 
20 to 44 years 6.93±7.73 
 
 
45+ years 7.24±7.81 
 
Gender Male  8.03±9.11 0.655 
 
Female 7.81±8.53 
 
Diabetes Yes 8.04± 8.87 0.019 
 
No 7.90± 8.81 
 
Hypertension Yes 8.22±9.18 <0.001 
 
No 7.88± 8.77 
 
Asthma Yes 10.25±11.06 <0.001 
 
No 7.73± 8.59 
 
Dyslipidaemia Yes  8.39±9.20 <0.001 
 
No 7.89± 8.79 
 
Obesity Yes 8.50±8.92 <0.001 
 
No 7.89±8.81 
 
*p-value <0.05 significant, based on non-parametric Mann-Whitney and Kruskal-Wallis 
test.  
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Table-11 shows the distribution and bi-variate analysis of individual patient-level number 
of RTI related investigations use across age-categories, gender and various comorbidity 
status. The mean ±SD number of the Investigations use varies significantly (p-value 
<0.001) among the different age groups. Age group less than 5 years (0.21±3.56) had the 
highest and 45+ years (2.62±2.69) had the lowest mean number of investigations use. The 
mean ±SD use of investigations use in Diabetes (0.11±0.38, p-value <0.001), Hypertension 
(0.11±0.36, p-value <0.001), Dyslipidaemia (0.10±0.35, p-value<0.001) and Obesity 
(0.13±0.41, p-value <0.001) was showing statistically significant result. 
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Table-11: Bi-variate analysis of individual patient-level number of investigations use 
during July 2015 to December 2017 (N=58,786). 
 
Variables 
 
Number of Investigations use 
     Mean ±SD 
p-value 
Age Groups <5 years 0.21±0.54 <0.001 
 
5 to 19 years 0.16 ± 0.45  
 
 
20 to 44 years 0.12±0.38  
 
 
45+ years 0.10±0.34  
 
Gender Male 0.14±0.43 0.306 
 
Female 0.14±0.42  
 
Diabetes Yes 0.11±0.38     <0.001 
 
No 0.14±0.43  
 
Hypertension Yes 0.11±0.36  <0.001 
 
No 0.14±0.43  
 
Asthma Yes 0.15±0.45    0.078 
 
No 0.14±0.42  
 
Dyslipidaemia Yes 0.10±0.35  <0.001 
 
No 0.14±0.43   
 
Obesity Yes 0.13±0.41   0.019 
 
No 0.14±0.42  
 
  
*p-value <0.05 significant, based on non-parametric Mann-Whitney and Kruskal-Wallis 
test.  
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Determinants by Negative Binomial regression analysis: 
 
Negative Binomial regression analysis of factors associated with RTI related GP visits: 
After univariate analysis, all variables had p value <0.25, so they were all included 
in the initial full model. In the next step all the variables were statistically significant (p 
<0.05). The significant predictors identified by our analysis (the final model) consisted of 
seven variables: Age category, Gender, Diabetes Mellitus, Hypertension, Asthma, 
Dyslipidaemia and Obesity which were found to be the significant predictors for RTI 
related GP visits in the context of our study and available data.  
Table-12 is showing results of Negative Binomial Regression analysis of significant 
predictors of RTI related GP visits. Incidence Rate Ratio (IRR) for age category 5 to 19 
years (IRR=0.98, 95% CI= 0.95 to 1.02, p-value =0.031) indicates that the incident rate for 
5 to 19 years is 0.98 times the incident rate for the reference group (<5 years), holding the 
other variables constant and the result is not significant. For age category 20 to 44 years 
(IRR=0.76, 95% CI= 0.74 to 0.79, p-value <0.001) indicates that the incident rate for 20 to 
44 years is 0.76 times the incident rate for the reference group (<5 years), holding the other 
variables constant and the result is significant. For age category 45+ years (IRR=0.71, 95% 
CI= 0.68 to 0.74, p-value <0.001) indicates that the incident rate for 45+years is 0.71 times 
the incident rate for the reference group (<5 years), holding the other variables constant 
and the result is significant. The IRR for the Gender- male (IRR=1.02, 95% CI= 1.00 to 
1.04, p-value=0.01) demonstrated that the incident rate for gender-male is 2% significantly 
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higher when compared to the reference group (female), holding the other variables 
constant.  
The IRR for the Diabetes Mellitus (IRR=1.08, 95% CI= 1.04 to 1.12, p-value <0.001) 
indicates that the incident rate for Diabetes Mellitus patient is 8% significantly higher when 
compared to the reference group (no diabetes), holding the other variables constant. For 
the variable Hypertension (IRR=1.14, 95% CI= 1.10 to 1.19, p-value <0.001) indicates that 
the incident rate for Hypertensive patient is 14% significantly higher when compared to 
the reference group (no hypertension), holding the other variables constant. For the variable 
Asthma (IRR=1.46, 95% CI= 1.41 to 1.51, p-value <0.001) indicates that the incident rate 
for Asthma patient is 46% significantly higher when compared to the reference group (no 
asthma), holding the other variables constant. The IRR for the Dyslipidaemia (IRR=1.11, 
95% CI= 1.06 to 1.16, p-value <0.001) indicates that the incident rate for Dyslipidaemia 
patient is 11% significantly higher when compared to the reference group (no 
dyslipidaemia), holding the other variables constant. For the variable Obesity (IRR=1.09, 
95% CI= 1.04 to 1.13, p-value <0.001) indicates that the incident rate for obese patient is 
9% significantly higher when compared to the reference group (no obesity), holding the 
other variables constant. 
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Table-12: Negative Binomial Regression analysis of significant predictors of RTI related 
GP visits (N=58,786). 
 
Variables IRR P value 95% C. I. 
 
Age category 
  
Lower Upper 
<5 years 1 (Reference) 
   
5 to 19 years 0.98 0.31 0.95 1.02 
20 to 44 years 0.76 <0.001 0.74 0.79 
45+ years 0.71 <0.001 0.68 0.74 
Gender 
    
Female 1 (Reference) 
   
Male 1.02 0.01 1.00 1.04 
Diabetes Mellitus 
    
No 1 (Reference) 
   
yes 1.08 <0.001 1.04 1.12 
Hypertension 
    
No 1 (Reference) 
   
Yes 1.14 <0.001 1.10 1.19 
Asthma 
    
No 1 (Reference) 
   
yes 1.46 <0.001 1.41 1.51 
Dyslipidaemia 
    
No 1 (Reference) 
   
yes 1.11 <0.001 1.06 1.16 
Obesity 
    
No 1 (Reference) 
   
yes 1.09 <0.001 1.04 1.13 
 
*RTI= Respiratory Tract Infection *p-value <0.05 significant *IRR= Incidence Rate 
Ratio 
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Negative Binomial regression analysis of factors associated with Antibiotic use: 
After univariate analysis, four variables: age category, gender, diabetes, asthma and 
obesity had p value <0.25, so they were included in the initial full model. In the next step 
variables age category, diabetes, asthma and obesity were statistically significant (p <0.05) 
and variable gender were not and removed from the model (p>0.05). Comparing the initial 
full model with the smaller one by using Likelihood-ratio test (LRT) was in favour of the 
smaller model (p-value= 0.105). The significant predictors identified by our analysis (the 
final model) consisted of four variables: Age category, Diabetes Mellitus, Asthma and 
Obesity which were found to be the significant predictors for Antibiotic use in the 
background of our study and available data.  
Table-13 provides the result of Negative Binomial Regression analysis of significant 
predictors of RTI related Antibiotics use. IRR for age category 5 to 19 years (IRR=0.90, 
95% CI= 0.86 to 0.94, p-value <0.001) indicates that the incident rate for 5 to 19 years is 
0.90 times the incident rate for the reference group (<5 years), holding the other variables 
constant and the result is significant. For age category 20 to 44 years (IRR=0.64, 95% CI= 
0.61 to 0.67, p-value <0.001) indicates that the incident rate for 20 to 44 years is 0.64 times 
the incident rate for the reference group (<5 years), holding the other variables constant 
and the result is significant. For age category 45+ years (IRR=0.62, 95% CI= 0.58 to 0.64, 
p-value <0.001) indicates that the incident rate for 45+years is 0.62 times the incident rate 
for the reference group (<5 years), holding the other variables constant and the result is 
significant. 
   
53 
 
The IRR for the Diabetes Mellitus (IRR=1.09, 95% CI= 1.04 to 1.13, p-value=0.02) 
indicates that the incident rate for Diabetes Mellitus patient is 9% significantly higher when 
compared to the reference group (no diabetes), holding the other variables constant. For 
the variable Asthma (IRR=1.46, 95% CI= 1.39 to 1.53, p-value <0.001) indicates that the 
incident rate for Asthma patient is 46% significantly higher when compared to the 
reference group (no asthma), holding the other variables constant. For the variable Obesity 
(IRR=1.16, 95% CI= 1.09 to 1.23, p-value <0.001) indicates that the incident rate for obese 
patient is 16% significantly higher when compared to the reference group (no obesity), 
holding the other variables constant. 
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Table-13: Negative Binomial Regression analysis of significant predictors of RTI related 
Antibiotics use (N=58,786). 
 
Variables IRR P value 95% C. I. 
 
Age category 
  
Lower Upper 
<5 years 1(Reference) 
   
5 to 19 years 0.90 <0.001 0.86 0.94 
20 to 44 years 0.64 <0.001 0.61 0.67 
45+ years 0.59 <0.001 0.58 0.64 
Diabetes Mellitus 
    
No 1 (Reference) 
   
yes 1.09 0.017 1.04 1.13 
Asthma 
    
No 1 (Reference) 
   
yes 1.46 <0.001 1.39 1.53 
Obesity 
    
No 1 (Reference) 
   
yes 1.16 <0.001 1.09 1.23 
 
*RTI= Respiratory Tract Infection *p-value <0.05 significant *IRR= Incidence Rate 
Ratio 
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Negative Binomial regression analysis of factors associated with other medication use: 
After univariate analysis, all the seven variables: age category, gender, diabetes, 
hypertension, asthma, dyslipidaemia and obesity had p value <0.25, so they were included 
in the initial full model. In the next step variables age category, diabetes, hypertension, 
asthma, dyslipidaemia and obesity were statistically significant (p <0.05) and variable 
gender were not and removed from the model (p>0.05). Comparing the initial full model 
with the smaller one by using Likelihood-ratio test (LRT) was in favour of the smaller 
model (p-value= 0.067). The significant predictors identified by our analysis (the final 
model) consisted of four variables: Age category, diabetes, hypertension, asthma, 
dyslipidaemia and obesity which were found to be the significant predictors for 
medications use in the context of our study and available data.  
Table-14 gives the result of Negative Binomial Regression analysis of significant 
predictors of RTI related other medications use. IRR for age category 5 to 19 years 
(IRR=0.91, 95% CI= 0.88 to 0.94, p-value <0.001) indicates that the incident rate for 5 to 
19 years is 0.91 times the incident rate for the reference group (<5 years), holding the other 
variables constant and the result is significant. For age category 20 to 44 years (IRR=0.68, 
95% CI= 0.66 to 0.70, p-value <0.001) indicates that the incident rate for 20 to 44 years is 
0.68 times the incident rate for the reference group (<5 years), holding the other variables 
constant and the result is significant. For age category 45+ years (IRR=0.62, 95% CI= 0.59 
to 0.65, p-value <0.001) indicates that the incident rate for 45+years is 0.62 times the 
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incident rate for the reference group (<5 years), holding the other variables constant and 
the result is significant. 
The IRR for the Diabetes Mellitus (IRR=1.08, 95% CI= 1.04 to 1.12, p-value <0.001) 
indicates that the incident rate for Diabetes Mellitus patient is 8% significantly higher when 
compared to the reference group (no diabetes), holding the other variables constant. For 
the variable Hypertension (IRR=1.14, 95% CI= 1.09 to 1.19, p-value <0.001) indicates that 
the incident rate for Hypertensive patient is 14% significantly higher when compared to 
the reference group (no hypertension), holding the other variables constant. For the variable 
Asthma (IRR=1.47, 95% CI= 1.42 to 1.52, p-value <0.001) indicates that the incident rate 
for Asthma patient is 47% significantly higher when compared to the reference group (no 
asthma), holding the other variables constant. The IRR for the Dyslipidaemia (IRR=1.10, 
95% CI= 1.05 to 1.16, p-value <0.001) indicates that the incident rate for Dyslipidaemia 
patient is 10% significantly higher when compared to the reference group (no 
dyslipidaemia), holding the other variables constant. For the variable Obesity (IRR=1.11, 
95% CI= 1.04 to 1.16, p-value <0.001) indicates that the incident rate for obese patient is 
11% significantly higher when compared to the reference group (no obesity), holding the 
other variables constant. 
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Table-14: Negative Binomial Regression analysis of significant predictors of RTI related 
other medications use (N=58,786). 
 
Variables IRR P value 95% C. I. 
Age category 
  
Lower Upper 
<5 years 1(Reference) 
   
5 to 19 years 0.91 <0.001 0.88 0.94 
20 to 44 years 0.68 <0.001 0.66 0.70 
45+ years 0.62 <0.001 0.59 0.65 
Diabetes Mellitus 
    
No 1 (Reference) 
   
yes 1.08 <0.001 1.04 1.12 
Hypertension 
    
No 1 (Reference) 
   
yes 1.14 <0.001 1.09 1.19 
Asthma 
    
No 1 (Reference) 
   
yes 1.47 <0.001 1.42 1.52 
Dyslipidaemia 
    
No 1 (Reference) 
   
yes 1.10 <0.001 1.05 1.16 
Obesity 
    
No 1 (Reference) 
   
yes 1.11 <0.001 1.04 1.16 
 
*RTI= Respiratory Tract Infection *p-value <0.05 significant *IRR= Incidence Rate 
Ratio 
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Negative Binomial regression analysis of factors associated with RTI related investigations 
use: 
After univariate analysis, six variables: age category, diabetes, hypertension, 
asthma, dyslipidaemia and obesity had p value <0.25, so they were included in the initial 
full model. In the next step variables age category and asthma were statistically significant 
(p <0.05) and variable gender, diabetes, hypertension, dyslipidaemia and obesity were not 
and removed from the model (p>0.05). Comparing the initial full model with the smaller 
one by using Likelihood-ratio test (LRT) was in favour of the smaller model (p-value= 
0.099). The significant predictors identified by our analysis (the final model) consisted of 
two variables: Age category and asthma which were found to be the significant predictors 
for medications use in the context of our study and available data.  
Table-15 is demonstrating the result of Negative Binomial Regression analysis of 
significant predictors of RTI related Investigations use IRR for age category 5 to 19 years 
(IRR=0.76, 95% CI= 0.71 to 0.82, p-value <0.001) indicates that the incident rate for 5 to 
19 years is 0.71 times the incident rate for the reference group (<5 years), holding the other 
variables constant and the result is significant. For age category 20 to 44 years (IRR=0.52, 
95% CI= 0.48 to 0.56, p-value <0.001) indicates that the incident rate for 20 to 44 years is 
0.52 times the incident rate for the reference group (<5 years), holding the other variables 
constant and the result is significant. For age category 45+ years (IRR=0.40, 95% CI= 0.35 
to 0.44, p-value <0.001) indicates that the incident rate for 45+years is 0.40 times the 
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incident rate for the reference group (<5 years), holding the other variables constant and 
the result is significant. 
For the variable Asthma (IRR=1.44, 95% CI= 1.32 to 1.57, p-value <0.001) indicates that 
the incident rate for Asthma patient is 44% significantly higher when compared to the 
reference group (no asthma), holding the other variables constant. 
 
 
Table-15: Negative Binomial Regression analysis of significant predictors of RTI related 
Investigations use (N=58,786). 
 
Variables IRR P value 95% C. I. 
 
Age category 
    
<5 years 1(Reference) 
   
5 to 19 years 0.76 <0.001 0.71 0.82 
20 to 44 years 0.52 <0.001 0.48 0.56 
45+ years 0.39 <0.001 0.35 0.44 
Asthma 
    
No 1 (Reference) 
   
yes 1.42 <0.001 1.32 1.57 
 
*RTI= Respiratory Tract Infection *p-value <0.05 significant *IRR= Incidence Rate Ratio  
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CHAPTER 5: DISCUSSIONS AND CONCLUSIONS 
 
We have analysed selected healthcare services use data for RTI patients who 
attended 7 primary healthcare centres in Qatar during July 2015 to December 2017. We 
have selected these four healthcare services because we wanted to investigate the clinical 
burden or utilization related to RTIs. We have observed the highest rate of RTI-related GP 
visits, antibiotics and other medications use, tests & investigations among young Qatari 
patients, and patients with diabetes, hypertension and asthma. The findings were also in 
accordance with studies from the UK (40), USA (52), Australia (43) and Netherlands (44). 
Our study showed that RTI-related GP visits monthly rates and antibiotics use monthly 
rates overall decreased from 2015 to 2017, but for the antibiotic rates the result was 
significant. Monthly rates of other medications use didn’t show a clear trend, but tests and 
investigations were showing significant increasing trend. Similar studies also showed 
decreasing trend, they explained this decreasing trend because of implementation of 
antimicrobial stewardship program. No clear explanation was found related to increasing 
trend of tests and investigation, although they suspect this might be due to cultural impact 
and patients’ demand for healthcare services use because in Qatar, patients doesn’t have to 
pay for the services  (52) (53). Also, there is a general tendency observed among clinicians 
in Qatar to advise excessive tests and investigations for patients which might not be needed. 
It is evident that RTI related antibiotic use has declined during 1990s, however, has 
remained unchanged since then (54). In the UK, there has been a long-term decrease in the 
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rate of General Practitioner (GP) consultations sought and antibiotic prescribing for 
managing respiratory infections (55). From a study conducted in Southern Sweden (56), 
revealed that there has been a reduction of 12% and 10% in yearly primary care 
consultation rates for acute tonsillitis and AOM between 1999 and 2005.   
Several studies (57) (58) have stated the importance of antimicrobial stewardship program 
in relation to the reduction of use of healthcare services because the reduction in 
antimicrobial consumption in relation with the attainments of clinical outcomes and 
prevention of other harmful effects, including death and new events of RTI, have a 
definitive effect on the utilization of funds and resources.   
According to (Al-Niemat & Gunn et al.,2014) observing infection related practitioners 
visits and antimicrobial utilization has been viewed as a fundamental part of antimicrobial 
stewardship programs, nevertheless inspecting the nature of solutions for curative or 
prophylactic use in the diverse settings amid understanding consideration, including the 
emergency department, inpatient, or outpatient facilities (59) (60) 
As expected, the finding of our study producing lower number of RTI related resource use 
during the summer months. In general, the new event of RTIs is higher in the winter 
months. Yet, the populace movement patterns in the GCC states are such that a huge section 
of migrant workforces return to their home states during the summer break, and the Qatari 
nationals travel overseas for leisure. A smaller Qatari population would lead to a smaller 
denominator of persons looking for treatment, and a smaller overall population may be 
related with lower transmission rates. Whether the lower figures in Qatar during the 
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summer months are due to the usual epidemiological patterns seen everywhere the world, 
or to a much lesser populace base in those months, warrants additional study (61). 
After the bi-variate analysis of individual patient-level data of selected 4 healthcare 
services across age-categories, gender and various comorbidity status, we found health care 
services varied significantly across age-categories, younger patients relatively used more 
healthcare services compared to older patients. Different studies also showed similar result, 
for the reason they explained that younger patients are more susceptible to RTI because for 
several reasons, nasal or respiratory discharges from children and young with viral RTIs 
comprise more viruses than those from infected adults. This increased output of viruses, 
along with typically lesser attention to hygiene, makes children and young more likely to 
spread their infection to others. The likelihood of spread is further boosted when several 
children and young are gathered together, such as in child care centres, schools and playing 
grounds (62). Also, patients with co-morbidities used on average more compared to 
patients without co-morbidities. 
We have found that age and comorbidity status (whether patients had a comorbidity or not) 
were important predictors for determining individual patient-level healthcare services use. 
For the RTI related GP visits and other medications use the predictors were almost same 
i.e. age-categories, diabetes mellitus, hypertension, asthma, dyslipidemia, and obesity. For 
the RTI related antibiotic use age-categories, diabetes mellitus, asthma, obesity was 
identified as a significant predictor but for RTI related investigations only age-category 
and asthma were identified as significant predictors. The findings were similar with other 
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studies. In a recent systematic review, McKay et al. (2016) investigated a wide range of 
factors associated with antibiotic prescribing for RTIs. The authors found ten studies that 
explored Gender as a possible factor, and just one study (Kozyrskyj et al., 2004) showed a 
statistically significant association between male sex and higher odds of antibiotic 
prescriptions. Nineteen studies explored age as a factor, 10 suggested older people had 
higher odds/risk of prescription than younger and 3 suggested younger people had higher 
risks of antibiotic prescriptions. Nine studies in the review examined association between 
comorbidities and antibiotic prescribing for RTIs. Two of these studies found presence of 
comorbidities was associated with prescribing, however, the type of comorbidities was 
varied by studies (63) (64). 
 
Strengths of the study: 
 
1. One of the main strengths of the study is that, there has never been such study before 
which investigated the pattern, distribution and trend of primary healthcare services use by 
local RTI patients using the routine observational data. So, these research results are 
expected to provide a wider, broader assessment of the healthcare services use associated 
with the managing of RTIs, from the perspective of both healthcare service provider and a 
patient. 
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2. We used a national level electronic database which ensured complete and valid routine 
observational data from the GPs, making the results generalizable to the other similar 
settings depending on the results based on appropriate statistical methods. 
3. The results are based on appropriate statistical methods, which are clinically meaningful 
and in line with those observed in the literature 
 
Weaknesses of the study: 
 
1- There are total 23 PHCCs in Qatar but the CERNER electronic database has complete 
patient-level information for only 7 primary healthcare centres over the study period. The 
availability of primary care electronic database in Qatar has also restricted the study 
duration for only being 2 and half years. But the study assumed it will not hamper the result 
because these selected healthcare centres are largest among other centres, also the 
geographic distribution of Qatar and services that are available in the PHCCs are almost 
same. 
2- The study couldn’t capture RTI-related healthcare services at hospitals due to data 
linkage issue but it will not impact the study results because the study focus was to 
investigate the utilization of healthcare services at primary care level. 
3- Not many individual-level information from the current version of the CERNER system. 
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4- This was an observational study with no intention to intervene in the on-going treatment, 
thus the final diagnoses registered for each patient were not confirmed by results from 
microbiology tests or from culture and sensitivity test. The absence of results from 
microbiology and culture and sensitivity tests will make it difficult to decide whether 
diagnosis or treatment was rational or not and misclassification of diagnosis which may 
leads to overestimation or underestimation of association. 
 
Further Research: 
There are total 23 PHCCs in Qatar but the CERNER electronic database has 
complete patient-level information for only 7 primary healthcare centres. The accessibility 
of primary care electronic database in Qatar has also restricted the study duration for only 
being 2 and half years. For further research all 23 PHCCs with at least 5years more patient 
level complete data along with other health care services i.e. Number of patients referred 
to hospital, number of specialist visits, number of emergency visits and Length of hospital 
stay could be included. 
Also, our study only included the Qatari population, for further research both Qatari and 
non-Qatari could be included to get the full picture and along with healthcare resource 
burden, economic burden could be investigated. 
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Concluding Remarks: 
The study reveals that, monthly rate of antibiotic consumptions by Qatari patients 
for RTIs decreased by about one antibiotic per 1000 all-cause visits, as did consultation 
rates but tests and investigations usage rate significantly increased. The large seasonal 
variation indicates additional likelihoods to decrease healthcare resource use. After the bi-
variate analysis of individual patient-level data of selected 4 healthcare services across age-
categories, gender and various comorbidity status, healthcare services varied significantly 
across age-categories (younger patients relatively used more healthcare services compared 
to older patients) and whether patients had one of the five comorbidities. We have also 
found that age and comorbidity status (whether patients had a comorbidity or not) were 
important predictors for determining individual patient-level healthcare services use.  
Decision makers will decide whether these selected healthcare services utilization by RTI 
patients at primary care setting are still a clinical burden, however, the evidence generated 
in this study will facilitates an effective and efficient use of services needed to manage 
these patients. Strengthening of signs and symptoms of viral respiratory illnesses, as well 
as supportive clear communication between physicians and patients, may be useful areas 
of focus. The study results may help policymakers to comprehend the scale of the burden 
and to plan a better management of RTIs at primary care setting in Qatar. It may also assist 
the Government to organize and ensure efficient wellbeing for its RTI patients with limited 
resources. 
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